PDCD1 and melanoma: Similarly, responders to anti-PD-1 therapy had an increased expression of IFN-related genes (e.g., IRF1, TNF, IFNG, and STAT1) [69], while suppression of this pathway was associated with immune evasion and poor response to immunotherapy in melanoma patients [34].